Kimberly Kay Kozeliski, NP

Kimberly Kozeliski practices at TriCore Reference Laboratories in Albuquerque, New Mexico.

Kimberly Kozeliski's NPI, 1144984063, was assigned on October 27, 2021. Kimberly Kozeliski holds New Mexico license 65686.

Kimberly Kozeliski's primary practice is TriCore Reference Laboratories, at 1001 Woodward Place Ne, Albuquerque, NM 87102. The practice phone is (505) 866-8866.

Kimberly Kozeliski's primary practice is TriCore Reference Laboratories in Albuquerque, New Mexico. The medical group on file is Lovelace Urgent Care. Dmand AI also links Kimberly Kozeliski to 1 more clinical lab, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kimberly Kozeliski practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Kimberly Kozeliski's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Kimberly Kozeliski is licensed in New Mexico.

CMS data shows 455 Medicare services from Kimberly Kozeliski across 3 procedure codes in 2024, for 153 Medicare patients. Medicare paid $25,709 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Kimberly Kozeliski in 2024. The largest group is 75 to 84, with 60 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kimberly Kozeliski's median patient age at 50, with 65% women.

In 2024, Kimberly Kozeliski wrote 232 Medicare Part D claims for 102 patients. 94% of them were for generic drugs. CMS names the drug for 57 of them, across 4 drugs with 11 or more claims each, at $283 in total drug cost.

Kimberly Kozeliski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 23 general payments to Kimberly Kozeliski from 9 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $285.